【结 构 式】 |
【分子编号】67027 【品名】benzyl 2-(2-benzyl-3-(4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)propanamido)acetate 【CA登记号】 |
【 分 子 式 】C32H38N2O4 【 分 子 量 】514.6648 【元素组成】C 74.68% H 7.44% N 5.44% O 12.43% |
与该中间体有关的原料药合成路线共 1 条
合成路线1
该中间体在本合成路线中的序号:(XV)
【1】 Li L, Tian QS, Wei WT, et al. 2003. Process for preparation of alvimopan and intermediates. 发明专利申请公开说明书, CN 1827598(Tianjiu Taipu Medicine Science and Technology Development Co, Ltd, Peop Rep China) |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 16618 | (3R,4R)-4-(3-isopropoxyphenyl)-1,3,4-trimethylhexahydropyridine; isopropyl 3-[(3R,4R)-1,3,4-trimethylhexahydro-4-pyridinyl]phenyl ether | C17H27NO | 详情 | 详情 | |
(II) | 67026 | (3R,4R)-phenyl 4-(3-isopropoxyphenyl)-3,4-dimethylpiperidine-1-carboxylate | C23H29NO3 | 详情 | 详情 | |
(III) | 16620 | 3-[(3R,4R)-3,4-dimethylhexahydro-4-pyridinyl]phenol | 119193-19-0 | C13H19NO | 详情 | 详情 |
(IV) | 10498 | Benzaldehyde;Benzoic aldehyde;Phenylmethanal | 100-52-7 | C7H6O | 详情 | 详情 |
(V) | 14156 | methyl acrylate | 96-33-3 | C4H6O2 | 详情 | 详情 |
(VI) | 49470 | methyl 2-[hydroxy(phenyl)methyl]acrylate | C11H12O3 | 详情 | 详情 | |
(VII) | 49475 | methyl (E)-2-[(acetoxy)methyl]-3-phenyl-2-propenoate | C13H14O4 | 详情 | 详情 | |
(VIII) | 49476 | (E)-2-(hydroxymethyl)-3-phenyl-2-propenoic acid | C10H10O3 | 详情 | 详情 | |
(IX) | 49480 | 2-benzyl-3-hydroxypropionic acid | C10H12O3 | 详情 | 详情 | |
(X) | 49481 | (2S)-2-benzyl-3-hydroxypropionic acid | C10H12O3 | 详情 | 详情 | |
(XI) | 13601 | benzyl 2-aminoacetate; Glycine benzyl ester hydrochloride | 1738-68-7 | C9H11NO2 | 详情 | 详情 |
(XII) | 49477 | benzyl 2-[[(2S)-2-benzyl-3-hydroxypropanoyl]amino]acetate | C19H21NO4 | 详情 | 详情 | |
(XIII) | 49478 | benzyl 2-([(2S)-2-benzyl-3-[(methylsulfonyl)oxy]propanoyl]amino)acetate | C20H23NO6S | 详情 | 详情 | |
(XIV) | 49479 | benzyl 2-[[(2S)-2-benzyl-3-bromopropanoyl]amino]acetate | C19H20BrNO3 | 详情 | 详情 | |
(XV) | 67027 | benzyl 2-(2-benzyl-3-(4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)propanamido)acetate | C32H38N2O4 | 详情 | 详情 |
Extended Information